BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 36845127)

  • 21. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
    Bläss S; Engel JM; Burmester GR
    Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].
    Seemayer CA; Distler O; Kuchen S; Müller-Ladner U; Michel BA; Neidhart M; Gay RE; Gay S
    Z Rheumatol; 2001 Oct; 60(5):309-18. PubMed ID: 11759230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated bioenergetics: a key regulator of joint inflammation.
    Biniecka M; Canavan M; McGarry T; Gao W; McCormick J; Cregan S; Gallagher L; Smith T; Phelan JJ; Ryan J; O'Sullivan J; Ng CT; Veale DJ; Fearon U
    Ann Rheum Dis; 2016 Dec; 75(12):2192-2200. PubMed ID: 27013493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cold atmospheric pressure plasma: A potential physical therapy for rheumatoid arthritis hyperplastic synovium.
    Ding C; Liu Q; Ouyang W; Sun Y; Liu Q; Gao S; Wu Z
    Int Immunopharmacol; 2023 Oct; 123():110732. PubMed ID: 37531824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis as a potential treatment strategy for rheumatoid arthritis.
    Wang Y; Wu H; Deng R
    Eur J Pharmacol; 2021 Nov; 910():174500. PubMed ID: 34509462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.
    Fresneda Alarcon M; McLaren Z; Wright HL
    Front Immunol; 2021; 12():649693. PubMed ID: 33746988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis.
    Remans PH; van Oosterhout M; Smeets TJ; Sanders M; Frederiks WM; Reedquist KA; Tak PP; Breedveld FC; van Laar JM
    Arthritis Rheum; 2005 Jul; 52(7):2003-9. PubMed ID: 15986371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Dysfunction in Rheumatoid Arthritis.
    Ma C; Wang J; Hong F; Yang S
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation.
    Hayer S; Bauer G; Willburger M; Sinn K; Alasti F; Plasenzotti R; Shvets T; Niederreiter B; Aschauer C; Steiner G; Podesser BK; Smolen JS; Redlich K
    Dis Model Mech; 2016 Nov; 9(11):1329-1338. PubMed ID: 27638666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis.
    Sun W; Ma J; Zhao H; Xiao C; Zhong H; Ling H; Xie Z; Tian Q; Chen H; Zhang T; Chen M; Jin S; Wang J
    Arthritis Res Ther; 2020 Mar; 22(1):61. PubMed ID: 32216830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis.
    Biniecka M; Fox E; Gao W; Ng CT; Veale DJ; Fearon U; O'Sullivan J
    Arthritis Rheum; 2011 Aug; 63(8):2172-82. PubMed ID: 21484771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen antagonizes ASIC1a-induced chondrocyte mitochondrial stress in rheumatoid arthritis.
    Zai Z; Xu Y; Qian X; Li Z; Ou Z; Zhang T; Wang L; Ling Y; Peng X; Zhang Y; Chen F
    J Transl Med; 2022 Dec; 20(1):561. PubMed ID: 36463203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanomedicine targeted anti-inflammatory therapy to deal with the 'crux' of rheumatoid arthritis.
    An M; Zhang J; Zhang X; Zhao Y; Liu Y
    J Drug Target; 2024 Apr; 32(4):381-392. PubMed ID: 38321981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of DNM1L and mitochondrial fission attenuates inflammatory response in fibroblast-like synoviocytes of rheumatoid arthritis.
    Wang X; Chen Z; Fan X; Li W; Qu J; Dong C; Wang Z; Ji Z; Li Y
    J Cell Mol Med; 2020 Jan; 24(2):1516-1528. PubMed ID: 31755231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
    Kaur S; White S; Bartold M
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients?
    Dénarié D; Constant E; Thomas T; Marotte H
    Mediators Inflamm; 2014; 2014():537324. PubMed ID: 24744505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox signaling in rheumatoid arthritis and the preventive role of polyphenols.
    Mateen S; Moin S; Zafar A; Khan AQ
    Clin Chim Acta; 2016 Dec; 463():4-10. PubMed ID: 27720800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid Arthritis and Oxidative Stress.
    Zamudio-Cuevas Y; Martínez-Flores K; Martínez-Nava GA; Clavijo-Cornejo D; Fernández-Torres J; Sánchez-Sánchez R
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):174-184. PubMed ID: 36227658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants.
    Bala A; Mondal C; Haldar PK; Khandelwal B
    Inflammopharmacology; 2017 Dec; 25(6):595-607. PubMed ID: 28929423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.